News

In patients with type 2 diabetes and CVD, the GIP/GLP-1 agonist was as good as the older drug, and possibly better in some ...
Michael Mack and Caroline Berchuck discuss how the expectations of healthcare delivery in the United States are shifting due ...
This raises the possibility that preventive strategies should vary based on the type of mitral surgery, but more research is ...
The condition, more severe than preeclampsia, should inspire close follow-up for hypertension, heart failure, and stroke.
Some good news, some ‘sobering,’ this month for tricuspid valve interventions, physician payments, and colchicine.
A joint SCCT/SCAI panel reviewed many opportunities for CT to enhance procedural planning and foster multidisciplinary care.
About 8% of all adults age 18 and older—more often men than women—received some treatment for heart disease in 2022.
The AF population is sicker than those in sinus rhythm and needs more attentive care, both before and after the procedure.
When considering lead replacement, physicians should weigh the risks and benefits of extraction versus abandonment.
The serial imaging substudy shows that intensive therapy might change plaque morphology positively, researchers say.
The decade-long, single-healthcare-system study gives insights into how physicians are using CAC tests and in which patients.
The Intrepid TMVR system just released 2-year transfemoral EFS outcomes at NY Valves. This discussion provides a deeper dive ...